HSCT

Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Assessing Pulmonary Changes in HSCT

Technical Development of Xe MRI

Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation Recipients

Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.

HBV Reactivation Prediction Model in Allo-HSCT

Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).

Gecacitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis

The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating

The Efficacy and Safety of Luspatercept in Improving Early Anemia After HSCT

Efficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALL

Neurocognitive Deficit After Paediatric Transplantation: Understanding the Role of Environment and Physical Function

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome

Zuberitamab for EBV Infection Post-Allo-HSCT

Modified Conditioning Regimen for CML-BP

Reduced-dose Conditioning Regimen Containing TBI in HSCT Treating Elderly Patients With Aplastic Anemia

Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALL

Comparison of Intralipid With SMOF Lipid Following HSCT